App-Quantinova.ai

Burnt out Diabetes: Cytokines, Adipokines and TLRs Modulation in Type 2 Diabetes

Saket Gupta - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Lutamin

Factors Associated with Insulin Independence after Total Pancreatectomy and Autologous Islet Cell Transplantation in Patients with Chronic Pancreatitis

Philip C. Johnston - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hereditary pancreatitis

N/A

Empagliflozin Reduces Blood Pressure in Patients with Type 2 Diabetes and Hypertension: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial (EMPA-REG BPTM)

Ilkka Tikkanen - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

BI-10773

Comparison of Gut Microbiota in Obese, Diabetic and Healthy Control Individuals

Yalcin Basaran - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Resistin and Obesity

Elena Parreno Caparros - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

Interleukin

Liver Steatosis in Obese Children and Its Associated Metabolic Impairment Are Influenced By Gender, Race and Pubertal Status and Reversed after Weight Reduction

Gabriel Angel Martos-Moreno - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acanthosis Nigricans

Ergocalciferol

Liraglutide 3.0 Mg Reduces the Prevalence of Prediabetes and Delays Onset of Type 2 Diabetes in Overweight and Obese Adults: Results from Scale Obesity and Prediabetes, a Randomized, Double-Blind and Placebo-Controlled 56-Week Trial

F Xavier Pi-Sunyer - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Liraglutide

New-Onset Type 1 Diabetes Mellitus Diagnosed Shortly after the Initiation of Treatment for Newly Diagnosed Grave-s Disease

Filippina Filia Dimitriadi - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

Cortrosyn

The Number of HLA Risk Haplotypes ARE Associated with the Severity of Insulin Deficiency in Recent-Onset Type 1 Diabetes

Rita A Gomez-Diaz - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

Proinsulin

Glycemic Variability and Nutrition Knowledge Measured By the Nutricarbquiz (NCQ) in Youth with Type 1 Diabetes

Lina Huerta Saenz - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Children and Adolescents with Type 1 Diabetes Have Similar Activity Levels to Healthy Children

Shaathanaa Kalyanasundram - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Characteristrics According to Autoantibodies and C-Peptide Level in Children and Adolescents with Diabetes Mellitus

Hyo-Kyoung Nam - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Incidence of Dyslipidemia and Its Association with Glycemic Control in Adolescents and Young Adults with Type 1 Diabetes

Shin-Hee Kim - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Microalbuminuria

N/A

Contrasting Effects of Aromatase Inhibition and Testosterone Therapy in Men with Severe Obesity: A Randomised Clinical Trial

Tomas Ahern - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

LPCN 1111

Michael Zitzmann - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

LPCN 1111

Autologus Hematopoietic Stem Cell Transplant in Type 1 Diabetes Mellitus in a Nonmyeloablative and Outpatient Setting

Olga Graciela Cantu-Rodriguez - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

Ciprofloxacin

Comparison of Glucose and Lipid Metabolism Abnormality during Nilotinib, Imatinib and Dasatinib Therapy Results of Enigma 2 Study

Racil Zdenek - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Nilotinib

Accelerated arterial stiffening occurs in obese and diabetic youth

Elaine M. Urbina - American Society of Hypertension (ASHy) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Type 2 diabetes mellitus

N/A

Combined Treatment of Intrapancreatic Autologous Bone Marrow Stem Cells and Hyperbaric Oxygen in Type 2 Diabetes Mellitus Randomized Clinical Trials

Esteban J. Estrada - American Society of Gene & Cell Therapy (ASGCT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Metformin Hydrochloride

Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot study.

Danielle Novetsky Friedman - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Mismatch repair deficiency

N/A

Filters

4759 Abstracts